ArticleScientific reports2024

Investigating the mechanisms underlying resistance to chemoterapy and to CRISPR-Cas9 in cancer cell lines.

Francesca Tomasi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.